Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Little Green Pharma Ltd. ( (AU:LGP) ) has provided an update.
Little Green Pharma has notified the market that a total of 586,540 share rights, across several ASX security codes (LGPAAB, LGPAAC, LGPAU and LGPAAA), have lapsed as of 13 January 2026 because the conditions attached to those rights were not satisfied or became incapable of being satisfied. The cessation of these conditional rights reduces the company’s potential future share dilution and slightly alters its issued capital profile, which may be relevant to existing shareholders and investors assessing LGP’s capital management and incentive structures.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is an Australian-listed company on the ASX (code: LGP), operating in the pharmaceutical and medicinal cannabis sector. The company issues share rights as part of its capital structure and incentive arrangements, reflecting a focus on equity-based compensation and capital management within public markets.
Average Trading Volume: 192,812
Technical Sentiment Signal: Sell
Current Market Cap: A$36.68M
See more data about LGP stock on TipRanks’ Stock Analysis page.